MedTrace Logo

Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

NCT04480580 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-07-21

No results posted yet for this study

Summary

We have herein analysed the patients admitted to our Department that underwent serologic tests for SARS-CoV-2 either by Ab or RT PCR, to estimate the prevalence of COVID-19 in the setting of a non-dedicated COVID-19 hospital and in a low CoV-2 incidence area, and to evaluate if security measures are necessary for this context.

Conditions

  • Covid19
  • Surgery
  • SARS (Severe Acute Respiratory Syndrome)

Interventions

DIAGNOSTIC_TEST

SARS-CoV-2 Ab

Patient test for specific antibodies for SARS-CoV-2

Sponsors & Collaborators

  • University of Cagliari

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-30
Primary Completion
2020-04-30
Completion
2020-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04480580 on ClinicalTrials.gov